The latest people and business news from the past month, all in one place.
WCG announced the appointment of Donna Snyder, MD, MBE, as executive physician. Before joining WCG, Snyder earned widespread recognition as an expert in applying scientific and ethical regulations related to the inclusion of children in clinical research and the development of pediatric products.
Phastar revealed the hiring of Graham Clark as its new CEO. Previously, Clark worked as the managing director at Phlexglobal, bringing with him over 25 years of experience in life sciences, financial, and professional services organizations.
Innovative Trials has been revealed as a finalist in the Lloyd's Bank British Business Excellence Awards. Previously, the company had been named a recipient of the Queen’s Award for international excellence and was named Best Global Patient Recruitment Company in 2021. In a separate press release, the company announced its intention to support funding for a new children’s cancer center at Great Ormond Street Hospital (GOSH) in London, UK.
Calyx announced the successful implementation of its technology by a pharmaceutical company to submit key regulatory information to the FDA during its recently completed electronic common technical document (eCTD) 4.0 implementation pilot program.
ArisGlobal stated its intention to relocate global headquarters to the Boston area. Previously, the company was based out of Miami.
Avance Clinical has been recognized as the recipient of the 2023 Customer Value Leadership Award by Frost & Sullivan. On a yearly basis, Frost & Sullivan presents the award to the company that demonstrates excellence in implementing strategies that proactively create value for its customers, focusing on improving the return on the investment that customers make in its services or products.
CluePoints has announced that its RBQMLive event has won Best Product in the experiential/event marketing category of this year’s Sales and Marketing Technology Awards (Sammys). RBQMLive is an annual event that brings together RBQM experts, clinical trial specialists, and curious listeners to discuss the adoption, utilization, and best practices of risk-based quality management (RBQM), a system for managing data quality throughout a clinical trial across the pharmaceutical sector. The Business Intelligence Group’s awards program is designed to recognize those organizations working to solve the challenges of connecting and collaborating with prospects and customers.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.